• Mehul Malhotra
    Mehul Malhotra
    • Get sharable images
    • Copy Link

    • Share on Facebook
    • Share on X
    • Share on LinkedIn
    • Share on BlueSky
    • Share on Threads
    • Share on Reddit
Mehul Malhotra logo
    • Change photo
  • Delete photo

Mehul Malhotra

  • 0 Followers

  • 2 Following

  • Epidemiology Dashboard: Transforming Disease Intelligence with Advanced Data AnalyticsEpidemiology Dashboard: Transforming Disease Intelligence with Advanced Data Analytics

    Epidemiology Dashboard: Transforming Disease Intelligence with Advanced Data Analytics

    In the rapidly evolving healthcare and pharmaceutical landscape, data plays a crucial role in understanding diseases, patient populations, and treatment needs. Epidemiology, which focuses on studying disease distribution and determinants within populations, has become a cornerstone for healthcare decision-making. However, the growing volume and complexity of epidemiological data require advanced tools that can organize, analyze, and visualize insights efficiently.

    Mehul Malhotra
    Mehul Malhotra
  • Ulefnersen Sales Forecast: Unlocking the Future of Precision ALS TherapyUlefnersen Sales Forecast: Unlocking the Future of Precision ALS Therapy

    Ulefnersen Sales Forecast: Unlocking the Future of Precision ALS Therapy

    The biotechnology landscape is rapidly evolving as targeted therapies reshape the treatment approach for complex neurological disorders. Among these emerging innovations, Ulefnersen has gained considerable attention due to its potential to address a specific genetic cause of amyotrophic lateral sclerosis (ALS). As research progresses and clinical trials continue to deliver promising insights, the Ulefnersen Sales Forecast suggests a strong future outlook driven by advancements in precision medicine, expanding diagnostic capabilities, and increasing investment in rare disease therapies.

    Mehul Malhotra
    Mehul Malhotra
  • Paltusotine: The Game-Changing Oral Therapy Rewriting the Rules of Acromegaly TreatmentPaltusotine: The Game-Changing Oral Therapy Rewriting the Rules of Acromegaly Treatment

    Paltusotine: The Game-Changing Oral Therapy Rewriting the Rules of Acromegaly Treatment

    For decades, patients diagnosed with acromegaly — a rare endocrine disorder caused by a benign pituitary adenoma that leads to excess growth hormone (GH) secretion — had limited options. They endured painful, monthly depot injections as the standard of care. That era is now being transformed by Paltusotine, a first-in-class, once-daily oral nonpeptide somatostatin receptor type 2 (SST2/SSTR2) agonist developed by Crinetics Pharmaceuticals. Marketed under the brand name PALSONIFY™, this revolutionary drug received U.S. FDA approval in September 2025, marking a turning point in the treatment of a condition that has long been underserved by convenient therapeutic options.

    Mehul Malhotra
    Mehul Malhotra
  • Nipocalimab: The Next Frontier in Immunology  Market Outlook, Drug Landscape & Key ManufacturersNipocalimab: The Next Frontier in Immunology  Market Outlook, Drug Landscape & Key Manufacturers

    Nipocalimab: The Next Frontier in Immunology Market Outlook, Drug Landscape & Key Manufacturers

    In the rapidly evolving landscape of immunology and rare disease therapeutics, Nipocalimab has emerged as one of the most promising investigational monoclonal antibodies of the decade. Developed by Janssen Research & Development (a Johnson & Johnson company), this FcRn (neonatal Fc receptor) blocker is redefining the treatment paradigm for a spectrum of antibody-mediated diseases. With multiple late-stage clinical programs and a growing body of supportive data, nipocalimab is steadily making its way from clinical trials to the cusp of commercial reality.

    Mehul Malhotra
    Mehul Malhotra
  • Top 10 Epidemiology Insights That Influence Licensing DecisionsTop 10 Epidemiology Insights That Influence Licensing Decisions

    Top 10 Epidemiology Insights That Influence Licensing Decisions

    Top 10 Epidemiology Insights That Influence Licensing Decisions

    Mehul Malhotra
    Mehul Malhotra
  • CT-388: The Next-Generation Dual Agonist Poised to Redefine Obesity and Metabolic Disease TreatmentCT-388: The Next-Generation Dual Agonist Poised to Redefine Obesity and Metabolic Disease Treatment

    CT-388: The Next-Generation Dual Agonist Poised to Redefine Obesity and Metabolic Disease Treatment

    CT-388: The Next-Generation Dual Agonist Poised to Redefine Obesity and Metabolic Disease Treatment

    Mehul Malhotra
    Mehul Malhotra
  • Top 10 Applications of Epidemiology Dashboards in Rare DiseasesTop 10 Applications of Epidemiology Dashboards in Rare Diseases

    Top 10 Applications of Epidemiology Dashboards in Rare Diseases

    Rare diseases, often referred to as orphan diseases, affect a relatively small percentage of the population, yet collectively impact millions of people worldwide. Due to limited patient pools, fragmented data, and complex disease biology, understanding rare diseases remains a significant challenge for researchers, pharmaceutical companies, and policymakers. This is where epidemiology dashboards have emerged as powerful tools, enabling stakeholders to visualize, analyze, and forecast disease trends with precision.

    Mehul Malhotra
    Mehul Malhotra
  • DUPIXENT Sales Forecast and Market Size Analysis – 2034DUPIXENT Sales Forecast and Market Size Analysis – 2034

    DUPIXENT Sales Forecast and Market Size Analysis – 2034

    DUPIXENT Sales Forecast and Market Size Analysis – 2034

    Mehul Malhotra
    Mehul Malhotra
  • Top 10 Epidemiology Data Points Investors Look For in BiotechTop 10 Epidemiology Data Points Investors Look For in Biotech

    Top 10 Epidemiology Data Points Investors Look For in Biotech

    Top 10 Epidemiology Data Points Investors Look For in Biotech

    Mehul Malhotra
    Mehul Malhotra
  • Top 10 Epidemiology Insights That Impact Drug Launch StrategyTop 10 Epidemiology Insights That Impact Drug Launch Strategy

    Top 10 Epidemiology Insights That Impact Drug Launch Strategy

    Bringing a new drug to market is one of the most complex and high-stakes undertakings in the pharmaceutical industry. Behind every successful launch lies a foundation of robust data — and epidemiology sits at the very heart of that foundation. Understanding disease prevalence, incidence trends, patient demographics, and unmet medical need is no longer optional; it is essential. Companies that leverage deep epidemiological intelligence gain a decisive edge in forecasting market potential, targeting the right patient populations, and timing their launches strategically.

    Mehul Malhotra
    Mehul Malhotra
  • Top 10 Epidemiology Dashboard Software for Outbreak Response (2026 Guide)Top 10 Epidemiology Dashboard Software for Outbreak Response (2026 Guide)

    Top 10 Epidemiology Dashboard Software for Outbreak Response (2026 Guide)

    In the era of emerging infectious diseases, public health agencies and healthcare organizations rely heavily on epidemiology dashboard software to detect, analyze, and respond to disease outbreaks quickly. These platforms integrate surveillance data, geospatial analytics, and real-time visualization tools to help epidemiologists monitor trends, identify clusters, and coordinate interventions.

    Mehul Malhotra
    Mehul Malhotra
  • Depemokimab Market: A New Era in Eosinophil-Driven Disease ManagementDepemokimab Market: A New Era in Eosinophil-Driven Disease Management

    Depemokimab Market: A New Era in Eosinophil-Driven Disease Management

    Depemokimab Market: A New Era in Eosinophil-Driven Disease Management

    Mehul Malhotra
    Mehul Malhotra
  • The Future of HIV Treatment: A Global BIKTARVY Market AnalysisThe Future of HIV Treatment: A Global BIKTARVY Market Analysis

    The Future of HIV Treatment: A Global BIKTARVY Market Analysis

    The Future of HIV Treatment: A Global BIKTARVY Market Analysis

    Mehul Malhotra
    Mehul Malhotra
  • Top 10 Epidemiology Dashboard Software by Market ShareTop 10 Epidemiology Dashboard Software by Market Share

    Top 10 Epidemiology Dashboard Software by Market Share

    In the era of data-driven healthcare and public health intelligence, epidemiology dashboard software has become essential for monitoring disease trends, analyzing patient populations, and forecasting outbreaks. Governments, pharmaceutical companies, research institutes, and healthcare providers increasingly rely on advanced epidemiology platforms to visualize real-world data, analyze disease burden, and support policy decisions.

    Mehul Malhotra
    Mehul Malhotra
  • Top 10 Real-Time Data Epidemiology Dashboards for Health DepartmentsTop 10 Real-Time Data Epidemiology Dashboards for Health Departments

    Top 10 Real-Time Data Epidemiology Dashboards for Health Departments

    In the modern public health landscape, real-time data has become essential for effective disease surveillance, outbreak monitoring, and healthcare decision-making. Health departments across the globe rely on advanced epidemiology dashboards to track disease patterns, analyze patient data, and respond quickly to emerging health threats. These platforms combine real-world data, predictive analytics, and API integrations to provide actionable insights for policymakers, epidemiologists, and healthcare organizations.

    Mehul Malhotra
    Mehul Malhotra
  • Top 10 Epidemiology Dashboards with API IntegrationsTop 10 Epidemiology Dashboards with API Integrations

    Top 10 Epidemiology Dashboards with API Integrations

    In the modern healthcare ecosystem, data-driven decision-making has become essential for public health authorities, pharmaceutical companies, and healthcare researchers. Epidemiology dashboards have emerged as powerful tools that enable organizations to track disease trends, analyze epidemiological patterns, and integrate data from multiple sources through APIs. These dashboards provide real-time insights, advanced analytics, and predictive modeling to support strategic healthcare planning.

    Mehul Malhotra
    Mehul Malhotra
  • Healthcare Pipeline Assessment: Driving Innovation in Pharma and HealthcareHealthcare Pipeline Assessment: Driving Innovation in Pharma and Healthcare

    Healthcare Pipeline Assessment: Driving Innovation in Pharma and Healthcare

    Healthcare Pipeline Assessment: Driving Innovation in Pharma and Healthcare

    Mehul Malhotra
    Mehul Malhotra
  • The Importance of Due Diligence in the Pharmaceutical IndustryThe Importance of Due Diligence in the Pharmaceutical Industry

    The Importance of Due Diligence in the Pharmaceutical Industry

    In the highly competitive and regulated pharmaceutical sector, due diligence in pharmaceutical industry plays a pivotal role in ensuring informed decision-making, minimizing risks, and maximizing value. Whether it involves mergers, acquisitions, licensing deals, or investments, pharmaceutical and biotech companies rely on comprehensive due diligence to evaluate opportunities, validate assets, and mitigate uncertainties.

    Mehul Malhotra
    Mehul Malhotra
  • Top 10 Epidemiology Tools with Predictive AnalyticsTop 10 Epidemiology Tools with Predictive Analytics

    Top 10 Epidemiology Tools with Predictive Analytics

    Top 10 Epidemiology Tools with Predictive Analytics

    Mehul Malhotra
    Mehul Malhotra
  • Top 10 Epidemiology Tools Transforming Disease SurveillanceTop 10 Epidemiology Tools Transforming Disease Surveillance

    Top 10 Epidemiology Tools Transforming Disease Surveillance

    The global landscape of public health has never demanded faster, smarter, or more connected disease surveillance systems. From emerging infectious outbreaks to chronic disease monitoring, epidemiologists and health authorities are under constant pressure to detect, analyze, and respond with speed and precision. Fortunately, a new generation of epidemiology tools is rising to meet the challenge — combining real-time data analytics, AI-driven forecasting, and interoperable dashboards to put actionable intelligence in the hands of decision-makers. In this comprehensive 2026 guide, we rank the top 10 epidemiology tools transforming disease surveillance, beginning with the platform setting the gold standard for pharma and public health intelligence.

    Mehul Malhotra
    Mehul Malhotra